Pharmaceutical giant Pfizer Inc. said Wednesday that it plans to apply for emergency use authorization in the United States for a potential COVID-19 vaccine “within days,” as it has shown the vaccine to be effective in clinical study.The two-dose vaccine, jointly developed with German firm BioNTech SE, met “all of the study’s primary efficacy endpoints,” the companies said in their press release, noting that an analysis indicated the vaccine was 95 percent effective in preventing the disease caused by the novel coronavirus.Last week, the companies released an interim analysis from the phase-th…
- Mississippi State Rep. Price Wallace Calls For State To ‘Succeed’ From U.S. After Biden Victory - November 23, 2020
- Trump formally requests recount in Georgia - November 22, 2020
- Porn star and three Marines, all white supremacists, charged in federal gun conspiracy - November 21, 2020
- Rudy Giuliani: From America’s Mayor to America’s Hack to America’s Punchline - November 20, 2020
- Judge stops White House from immediately expelling unaccompanied minors - November 18, 2020
- Trump Campaign’s Legal Team Shaken Up For 3rd Time In Pennsylvania, Rudy Giuliani Flubs Argument Before Court - November 18, 2020
- Pfizer to apply for U.S. authorization on COVID vaccine “within days” - November 18, 2020
- Georgia Secretary Of State Brad Raffensperger Says Lindsey Graham Asked Him To Discard Legally Cast Mail-In Ballots - November 17, 2020
- Trump Spends Time Tweeting & Golfing While Ignoring Official Duties - November 15, 2020
- Trump May Be High Risk To National Security As He Leaves Office Top-Secret Intelligence - November 14, 2020
